- Home
- STSS vs TLPH Comparison
STSS vs TLPH Comparison
Compare STSS & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | STSS | TLPH |
|---|---|---|
| Founded | 2017 | 2005 |
| Country | United States | United States |
| Employees | 55 | 12 |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.8M | 42.3M |
| IPO Year | N/A | 2010 |
Fundamental Metrics
Financial Performance| Metric | STSS | TLPH |
|---|---|---|
| Price | $1.84 | $0.81 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 246.3K | 146.6K |
| Earning Date | 04-06-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,151,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.42 | $0.38 |
| 52 Week High | $18.23 | $1.57 |
Technical Indicators
Market Signals| Indicator | STSS | TLPH |
|---|---|---|
| Relative Strength Index (RSI) | 47.21 | 46.40 |
| Support Level | $1.66 | $0.73 |
| Resistance Level | $2.00 | $0.87 |
| Average True Range (ATR) | 0.10 | 0.07 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 18.75 | 22.11 |
Price Performance
Historical ComparisonAbout STSS Sharps Technology Inc.
Sharps Technology Inc is a medical device and pharmaceutical packaging company offering patented, smart-safety syringe products to the healthcare industry. The Company's product lines focus on providing ultra-low waste capabilities that incorporate syringe technologies that use both passive and active safety features. The Company has adopted a digital asset treasury scheme focused on accumulating SOL, the native digital asset of the Solana blockchain, leveraging capital markets raises to power on-chain yield generation with the Solana Ecosystem.
About TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.